SG11202102682SA - Quinoline derivative used for treating small cell lung cancer - Google Patents

Quinoline derivative used for treating small cell lung cancer

Info

Publication number
SG11202102682SA
SG11202102682SA SG11202102682SA SG11202102682SA SG11202102682SA SG 11202102682S A SG11202102682S A SG 11202102682SA SG 11202102682S A SG11202102682S A SG 11202102682SA SG 11202102682S A SG11202102682S A SG 11202102682SA SG 11202102682S A SG11202102682S A SG 11202102682SA
Authority
SG
Singapore
Prior art keywords
lung cancer
small cell
cell lung
derivative used
quinoline derivative
Prior art date
Application number
SG11202102682SA
Other languages
English (en)
Inventor
Shanchun Wang
Ding Yu
Xunqiang Wang
Bangan Peng
Lu Liu
Jie Dai
Hang Zhou
Yadong Miao
Original Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chia Tai Tianqing Pharmaceutical Group Co Ltd filed Critical Chia Tai Tianqing Pharmaceutical Group Co Ltd
Publication of SG11202102682SA publication Critical patent/SG11202102682SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
SG11202102682SA 2018-09-18 2019-09-18 Quinoline derivative used for treating small cell lung cancer SG11202102682SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201811088089 2018-09-18
PCT/CN2019/106406 WO2020057539A1 (zh) 2018-09-18 2019-09-18 用于治疗小细胞肺癌的喹啉衍生物

Publications (1)

Publication Number Publication Date
SG11202102682SA true SG11202102682SA (en) 2021-04-29

Family

ID=69888373

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202102682SA SG11202102682SA (en) 2018-09-18 2019-09-18 Quinoline derivative used for treating small cell lung cancer

Country Status (7)

Country Link
US (1) US20220031689A1 (zh)
EP (1) EP3854396A4 (zh)
CN (3) CN117085016A (zh)
AU (1) AU2019344764A1 (zh)
CA (1) CA3112946A1 (zh)
SG (1) SG11202102682SA (zh)
WO (1) WO2020057539A1 (zh)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8148532B2 (en) 2007-03-14 2012-04-03 Guoqing Paul Chen Spiro substituted compounds as angiogenesis inhibitors
CN102344438B (zh) 2010-08-01 2014-02-19 正大天晴药业集团股份有限公司 喹啉衍生物的结晶及其制备方法
CN105311030B (zh) * 2014-06-06 2020-03-24 正大天晴药业集团股份有限公司 用于抗肿瘤的螺取代化合物
CN114652723A (zh) * 2014-12-09 2022-06-24 正大天晴药业集团股份有限公司 治疗非小细胞肺癌的喹啉衍生物
US9751859B2 (en) * 2015-05-04 2017-09-05 Advenchen Pharmaceuticals, LLC Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts

Also Published As

Publication number Publication date
US20220031689A1 (en) 2022-02-03
WO2020057539A1 (zh) 2020-03-26
EP3854396A4 (en) 2022-06-29
CN117085016A (zh) 2023-11-21
CN112533600A (zh) 2021-03-19
CN117085017A (zh) 2023-11-21
AU2019344764A1 (en) 2021-05-20
EP3854396A1 (en) 2021-07-28
CN112533600B (zh) 2023-07-14
CA3112946A1 (en) 2020-03-26

Similar Documents

Publication Publication Date Title
EP3641770A4 (en) METHOD OF TREATMENT OF CANCER
EP3443119B8 (en) Methods for lung cancer detection
EP3488001A4 (en) TREATMENT OF CANCER
EP3307876A4 (en) NK-92 CELLS MODIFIED TO TREAT CANCER
EP3288382A4 (en) METHOD FOR THE TREATMENT OF CANCER
HK1251862A1 (zh) 治療癌症的方法和組合物
EP3400010A4 (en) ANTI-HER2 COMBINATIONS FOR THE TREATMENT OF TUMORS
IL275337A (en) 1-(piperidinocarbonylmethyl)-2-oxopyrazine derivatives for cancer therapy
EP3092006A4 (en) Targeted therapy for small cell lung cancer
EP3407978A4 (en) COMBINATION THERAPY FOR TREATING CANCER
EP3606962A4 (en) TREATMENT METHODS FOR HIGH CD73 TUMORS
EP3285773A4 (en) POLY THERAPY FOR THE TREATMENT OF CANCER
EP3405203A4 (en) METHODS OF TREATING CANCER
EP3440112A4 (en) METHOD FOR THE TREATMENT OF CANCER
EP3389634A4 (en) METHOD FOR THE TREATMENT OF CANCER
EP3341080A4 (en) METHOD FOR THE TREATMENT OF CANCER
HK1252370A1 (zh) 用於治療非小細胞肺癌的治療方法和組合物
IL255079A0 (en) Methods of treating lung cancer
EP3389652A4 (en) METHODS OF TREATING CANCER
EP3443962A4 (en) QUINOLINE DERIVATIVE FOR THE TREATMENT OF ESTOMAC CANCER
IL287907A (en) Cancer treatment methods
EP3589659A4 (en) CANCER TREATMENT COMPOUNDS AND METHODS
EP3892282A4 (en) COMBINATIONS FOR TREATING CANCER
EP3713576A4 (en) CANCER TREATMENT METHODS
EP3260119A4 (en) Combination method for treating cancer